KLI

검색

Ulsan Univ. Repository

Browsing by 저자 : Sung-Bae Kim

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

가 나 다 라 마 바 사 아 자 차 카 타 파 하

또는 첫 단어:

정렬 기준:
정렬:
결과 수
저자 수

전체 결과 42건 중 1-42 번을 표시중입니다.

1 Article A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel Chemotherapy Young-Woong Won ; Jin-Hyoung Kang ; Jung Hye Kwon ; et al 2023
2 Article A phase 2 multicenter study of docetaxel-PM and trastuzumab-pkrb combination therapy in recurrent or metastatic salivary gland carcinomas Jiyun Lee ; Sehhoon Park ; Hyun Ae Jung ; et al 2023
3 Article A phase Ia/Ib study of novel anti-ErbB3 monoclonal antibody, barecetamab (ISU104) in refractory solid cancers and monotherapy or in combination with cetuximab in recurrent or metastatic head and neck cancer Seyoung Seo ; Bhumsuk Keam ; Seong Hoon Shin ; et al 2023
4 Article A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03) Dae-Won Lee ; Bhumsuk Keam ; Keun Seok Lee ; et al 2023
5 Article A Propensity Score-matched Analysis of Long-term Oncologic Outcomes After Nipple-sparing Versus Conventional Mastectomy for Locally Advanced Breast Cancer Zhen-Yu Wu ; Hyun Ho Han ; Hee Jeong Kim ; et al 2022
6 Article A Randomized Phase II Study of Anti-CSF1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple-Negative Breast Cancer Sherko Kuemmel ; Mario Campone ; Delphine Loirat ; et al 2022
7 Article Antibody-drug conjugates targeting Trop-2: Clinical developments in early breast cancer therapy Jae Ho Jeong ; Sung-Bae Kim 2022
8 Article Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a predictive biomarker for axitinib in adenoid cystic carcinoma Dong Hyun Kim ; Yoojoo Lim ; Chan-Young Ock ; et al 2023
9 Article Association between tumor 18 F-fluorodeoxyglucose metabolism and survival in women with estrogen receptor-positive, HER2-negative breast cancer Sun Young Chae ; Seol Hoon Park ; Hyo Sang Lee ; et al 2022
10 Article Breast Cancer Recurrence after Smooth vs. Textured Implant-Based Breast Reconstruction: A Matched Cohort Study Zhen-Yu Wu ; Hyun Ho Han ; Jing Han ; et al 2022
11 Article Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex Dieke J van Rees ; Panagiota Bouti ; Bart Klein ; et al 2022
12 Article Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01) Eun Joo Kang ; Yun-Gyoo Lee ; Bhumsuk Keam ; et al 2022
13 Article Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysis Berend J van der Wilk ; Ben M Eyck ; Wayne L Hofstetter ; et al 2022
14 Article Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel Joanne Wing Yan Chiu ; Soo Chin Lee ; James Chung-man Ho ; et al 2023
15 Article Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors with the Opposite Treatment Sequence in Hormone Receptor?Positive, HER2-Negative Metastatic Breast Cancer Hyehyun Jeong ; Jae Ho Jeong ; Jeong Eun Kim ; et al 2022
16 Article Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01) Yun-Gyoo Lee ; Eun Joo Kang ; Bhumsuk Keam ; et al 2023
17 Article Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial Katya Galactionova ; Sibylle Loibl ; Paola Salari ; et al 2022
18 Article CT Findings From Interstitial Lung Diseases in Patients With Metastatic Breast Cancer Treated With Fam-Trastuzumab Deruxtecan: A Single Institutional Experience Yoon Jung Jang ; Jae Ho Jeong ; Jeong Eun Kim ; et al 2022
19 Article Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories Suthinee Ithimakin ; Napa Parinyanitikul ; Sung-Bae Kim ; et al 2022
20 Article Immune repertoire and responses to neoadjuvant TCHP therapy in HER2-positive breast cancer Junyoung Shin ; Baknoon Ham ; Jeong-Han Seo ; et al 2023
21 Article Impact of Local Breast Cancer Recurrence on Reconstructed Breast in Nipple-Sparing Mastectomy with Immediate Reconstruction Zhen-Yu Wu ; Hyun Ho Han ; Jing Han ; et al 2022
22 Article Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01) Yun-Gyoo Lee ; Eun Joo Kang ; Bhumsuk Keam ; et al 2022
23 Article Ipatasertib plus paclitaxel for PIK3CA/AKT1/PTEN-altered hormone receptor-positive HER2-negative advanced breast cancer: primary results from cohort B of the IPATunity130 randomized phase 3 trial Nicholas Turner ; Rebecca A Dent ; Joyce O'Shaughnessy ; et al 2022
24 Article Knowledge, attitudes, and behaviors toward fertility preservation in patients with breast cancer: A cross-sectional survey of physicians Soo Yeon Baek ; Kyung-Hun Lee ; Sung-Bae Kim ; et al 2023
25 Article Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial Hope S Rugo ; Seock-Ah Im ; Fatima Cardoso ; et al 2023
26 Article Neoadjuvant endocrine therapy in ER-positive breast cancer: evolution, indication, and tailored treatment strategy Hyehyun Jeong ; Sung-Bae Kim 2023
27 Article Pathological complete response, long-term outcomes, and recurrence patterns in HER2-low versus HER2-zero breast cancer after neoadjuvant chemotherapy Sora Kang ; So H Lee ; Hee J Lee ; et al 2022
28 Article Prognostic implications of HER2 changes after neoadjuvant chemotherapy in patients with HER2-zero and HER2-low breast cancer Sora Kang ; So Heun Lee ; Hee Jin Lee ; et al 2023
29 Article Randomized phase III trial of a neoadjuvant regimen of four cycles of adriamycin plus cyclophosphamide followed by four cycles of docetaxel (AC4-D4) versus a shorter treatment of three cycles of FEC followed by three cycles of docetaxel (FEC3-D3) in node-positive breast cancer (Neo-shorter; NCT02001506) Inhwan Hwang ; Jeong Eun Kim ; Jae Ho Jeong ; et al 2023
30 Article Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esophageal Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors Jwa Hoon Kim ; Bokyung Ahn ; Seung-Mo Hong ; et al 2022
31 Article Response to letter entitled: Re: Pathologic Complete Responses, Long-term Outcomes, and Recurrence Patterns in HER2-low vs. HER2-zero Breast Cancer after Neoadjuvant Chemotherapy Sora Kang ; Sung-Bae Kim 2023
32 Article RNA Sequencing for Elucidating an Intronic Variant of Uncertain Significance (SDHD c.314+3A>T) in Splicing Site Consensus Sequences Hyunjung Gu ; Jinyoung Hong ; Woochang Lee ; et al 2022
33 Article Role of Esophagectomy after Chemoradiation Therapy in Patients with Locally Advanced Squamous Cell Carcinoma: A Comparative Analysis Stratified by Clinical Response to Chemoradiation Therapy Jesang Yu ; Jong Hoon Kim ; Sung-Bae Kim ; et al 2022
34 Article The efficacy of adjuvant chemotherapy with capecitabine and cisplatin after surgery in locally advanced esophageal squamous cell carcinoma: a multicenter randomized phase III trial Young Mog Shim ; Jeonghee Yun ; Young-Hyuck Im ; et al 2022
35 Article The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study Jwa Hoon Kim ; Seyoung Seo ; Jee Hyun Kim ; et al 2022
36 Article Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3) Morihito Okada ; Ken Kato ; Byoung Chul Cho ; et al 2022
37 Article Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study Lin Shen ; Ken Kato ; Sung-Bae Kim ; et al 2022
38 Article Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis Guy Jerusalem ; Yeon Hee Park ; Toshinari Yamashita ; et al 2022
39 Article Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer Shanu Modi ; William Jacot ; Toshinari Yamashita ; et al 2022
40 Article Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial Sara A Hurvitz ; Roberto Hegg ; Wei-Pang Chung ; et al 2023
41 Article Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial Fabrice André ; Yeon Hee Park ; Sung-Bae Kim ; et al 2023
42 Article Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy A Prespecified Analysis of the monarchE Randomized Clinical Trial Miguel Martin ; Roberto Hegg ; Sung-Bae Kim ; et al 2022

OAK Ulsan Univ. Repository는 국립중앙도서관 OAK Repository 보급사업으로 구축되었습니다.